New Brunswick Scientific Company Inc.

James T. Orcutt was employed by the Company in May, 2000 as President of the Life Science division and served in that capacity until his appointment as President of the Company on September 10, 2001. Mr. Orcutt was further appointed as Chief Operating Officer of the Company on February 23, 2004. Upon the retirement of Mr. Freedman on December 31, 2006, Mr. Orcutt became the Chief Executive Officer of the Company. Prior to joining the Company, Mr. Orcutt spent 5 years as Senior Vice President of Sales, Marketing and Development with Boekel Industries and 12 years with Barnstead/Thermolyne in various sales and marketing management positions. Prior to his employment with Barnstead/Thermolyne he was employed as a project engineer and a field engineer.

Mr. David Freedman is the founder and current CEO of New Brunswick Scientific Corporation (NBS) in Edison, NJ. NBS is a manufacturer of instrumentation for medical laboratories and employs approximately 400 people. Annual sales are over $50 million per annum. NBS is publicly traded on the NASDAQ. Mr. David Freedman has over 50 years of experience in managing a biomedical instrumentation company. He founded NBS in 1946. NBS's products, such as rotary shakers, fermentors and variety of incubators, quickly became standards in the fields of biochemistry and biotechnology. Mr. Freedman holds about 200 patents and has authored many scientific publications. Mr. Freedman founded six companies other than NBS, including Princeton AquaScience, Bioinstrument Company, Segnatron and others. He was a member of the Board of Directors of six companies. Currently, Mr. Freedman is Chairman of the Board and CEO of NBS.

Chandra's role is to support New Brunswick Scientific's distributors, agents and customers overseas, a job he has been carrying out admirably for the past 12 years.

Ms. Lavender, served as Administrative Assistant to Mr. David Freedman from 1970 until June 30, 1990, was appointed Secretary of the Company in 1985. Ms. Lavender retired from her position as Administrative Assistant effective June 30, 1990. Ms. Lavender continues to serve on a part-time basis and in an emeritus capacity as Secretary of the Company.

Ernest Gross is an attorney-at-law who retired in 1984 from Rutgers University where he had been a Professor and Associate Director of the Institute of Management and Labor Relations from 1971 to 1983.

Jerome Birnbaum, Ph.D. is a pharmaceutical R&D Consultant and is a Co-founder of Achillion Pharmaceuticals, Inc., a development stage biotechnology company. Previously, Dr. Birnbaum was employed by Merck and Co., Inc. from 1966-1987 in various positions culminating as Vice President, Microbiology and Agricultural Research. From 1987 until his retirement in January 2000 he was employed in various positions by Bristol-Myers Squibb Company culminating as Senior Vice President, Strategic R&D Operations.